Research Topic · Peer-Reviewed

Sars

SARS-CoV-2 is the severe acute respiratory syndrome coronavirus 2, a positive-sense single-stranded RNA betacoronavirus and the causative agent of COVID-19. It enters host cells primarily through binding of its spike glycoprotein to the ACE2 receptor, and its relatively large RNA genome accumulates mutations that ge…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 14× across the literature 🔖 ISSN 2691-8862 🗓 Reviewed July 2026

Overview

SARS-CoV-2 is the severe acute respiratory syndrome coronavirus 2, a positive-sense single-stranded RNA betacoronavirus and the causative agent of COVID-19. It enters host cells primarily through binding of its spike glycoprotein to the ACE2 receptor, and its relatively large RNA genome accumulates mutations that generate variants of concern with altered transmissibility, immune escape, and clinical impact. Transmission occurs chiefly via respiratory droplets and aerosols, and infection ranges from asymptomatic carriage to severe pneumonia, hyperinflammation, and multi-organ involvement. Understanding the virus has centered on its molecular evolution and phylogeny, spike-protein biology, viral kinetics, host immune and cytokine responses, intracellular replication cycle, diagnostic detection of variants, and the development of vaccines and therapeutics. The peer-reviewed research collected here in the journal's virology and infectious-disease corpus reflects these themes, including molecular evolutionary characterization of SARS-CoV-2 isolates and comparison with other human and animal coronaviruses based on spike-gene sequences, viral kinetics under chloroquine-based or standard care, vaccine development insights and challenges, spike-protein effects on interferon and cytokine gene expression, molecular screening of the B.1.1.7 variant from rapid-antigen samples, convalescent-plasma neutralizing antibodies, and analytical modeling of the intracellular SARS-CoV-2 life cycle. Together they situate SARS-CoV-2 within contemporary research on emerging viral pathogens and their treatment.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

SARS-CoV-2 affected cells Pathogeny and Therapy

M.R PonizovskiyCorresponding author
Kiev, Ukraine, “Kiev regional p/n hospital”, /Head of “Laboratory Biochemistry and Toxicology”
Exact topic International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-20-3538

How this research is being cited

The 12 articles above have been cited 14 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Sars, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Current Viruses and Treatment Methodologies (ISSN 2691-8862).

Journal editorial board
Dr. Anantha Harijith · United States

This page summarises published research for orientation; it is not medical or professional advice.